Cargando…

Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and β-Arrestins

The bioluminescence resonance energy transfer (BRET) technique has become extremely valuable for the real-time monitoring of protein–protein interactions in live cells. This method is highly amenable to the detection of G protein-coupled receptor (GPCR) interactions with proteins critical for regula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocan, Martina, Dalrymple, Matthew B., Seeber, Ruth M., Feldman, Brian J., Pfleger, Kevin D. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356007/ https://www.ncbi.nlm.nih.gov/pubmed/22654789 http://dx.doi.org/10.3389/fendo.2010.00012

Ejemplares similares

Application of BRET to monitor ligand binding to GPCRs
por: Stoddart, Leigh A, et al.
Publicado: (2015)

Receptor-Heteromer Investigation Technology and its application using BRET
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2012)

Catalytic activation of β-arrestin by GPCRs
por: Eichel, Kelsie, et al.
Publicado: (2018)

BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H(1) Receptor-Mediated G Protein Activation, Signaling and Interactions with GRKs and β-Arrestins
por: Verweij, Eléonore W. E., et al.
Publicado: (2022)

Experimental determination of the bioluminescence resonance energy transfer (BRET) Förster distances of NanoBRET and red-shifted BRET pairs
por: Weihs, Felix, et al.
Publicado: (2020)

New Insights into Arrestin Recruitment to GPCRs
por: Spillmann, Martin, et al.
Publicado: (2020)

Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET
por: Namkung, Yoon, et al.
Publicado: (2016)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
por: McCorvy, John D., et al.
Publicado: (2017)

The incidence of candidate binding sites for β-arrestin in Drosophila neuropeptide GPCRs
por: Taghert, Paul H.
Publicado: (2022)

Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin
por: Kahsai, Alem W., et al.
Publicado: (2023)

Unraveling Receptor Stoichiometry Using Bret
por: Felce, James H., et al.
Publicado: (2012)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Phosphorylation of β-arrestin2 at Thr(383) by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs
por: Cassier, Elisabeth, et al.
Publicado: (2017)

Neuropeptide GPCRs in Neuroendocrinology
por: Vaudry, Hubert, et al.
Publicado: (2014)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality
por: Siddiqui, Sana, et al.
Publicado: (2013)

REV, A BRET-Based Sensor of ERK Activity
por: Xu, Chanjuan, et al.
Publicado: (2013)

Comment on “The Use of BRET to Study Receptor-Protein Interactions”
por: Jockers, Ralf
Publicado: (2014)

β-arrestin mediates communication between plasma membrane and intracellular GPCRs to regulate signaling
por: DeNies, Maxwell S., et al.
Publicado: (2020)

Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016)

Neuropeptide GPCRs in C. elegans
por: Frooninckx, Lotte, et al.
Publicado: (2012)

GPCRs in Autocrine and Paracrine Regulations
por: Tse, Lap Hang, et al.
Publicado: (2019)

BRET biosensors to study GPCR biology, pharmacology, and signal transduction
por: Salahpour, Ali, et al.
Publicado: (2012)

Agonist mediated internalization of M(2 )mAChR is β-arrestin-dependent
por: Jones, Kymry T, et al.
Publicado: (2006)

Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias
por: Pearce, Abigail, et al.
Publicado: (2022)

Functional map of arrestin binding to phosphorylated opsin, with and without agonist
por: Peterhans, Christian, et al.
Publicado: (2016)

Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs
por: Grätz, Lukas, et al.
Publicado: (2022)

NanoBRET: The Bright Future of Proximity-Based Assays
por: Dale, Natasha C., et al.
Publicado: (2019)

Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018)

Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease
por: Tokmakova, Alina, et al.
Publicado: (2022)

Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells
por: Cai, Bo, et al.
Publicado: (2023)

Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation
por: Kumari, Punita, et al.
Publicado: (2017)

Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β‐Arrestin‐Independent Internalisation
por: Passoni, I., et al.
Publicado: (2016)

BRET Analysis of GPCR Dimers in Neurons and Non-Neuronal Cells: Evidence for Inactive, Agonist, and Constitutive Conformations
por: El Khamlichi, Chayma, et al.
Publicado: (2021)

Evolution of BRET Biosensors from Live Cell to Tissue-Scale In vivo Imaging
por: De, Abhijit, et al.
Publicado: (2013)

Temporal Profiling of Orexin Receptor-Arrestin-Ubiquitin Complexes Reveals Differences between Receptor Subtypes
por: Dalrymple, Matthew B., et al.
Publicado: (2011)

Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II
por: Vaudry, Hubert, et al.
Publicado: (2023)

Editorial: Peptide-binding GPCRs coming of age
por: Di Pizio, Antonella, et al.
Publicado: (2023)

Editorial: Molecular modulators of GPCRs signal transduction
por: Vrecl, Milka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1137f5tuk60a4gjribtb5ujtro